Oct 01, 2021 · This is the American ICD-10-CM version of Z30.46 - other international versions of ICD-10 Z30.46 may differ. Applicable To Encounter for checking, reinsertion or removal of implantable subdermal contraceptive The following code (s) above Z30.46 contain annotation back-references that may be applicable to Z30.46 : Z00-Z99
Encounter for checking, reinsertion or removal of implantable subdermal contraceptive. ICD-10-CM Diagnosis Code Z30.017 [convert to ICD-9-CM] Encounter for initial prescription of implantable subdermal contraceptive. Enctr for init prescription of implntbl subdermal contracep. ICD-10-CM Diagnosis Code Z30.017.
The following codes can be used when inserting and removing contraceptive implants in an outpatient setting: ICD-10 Diagnosis Codes Z30.017 Encounter for initial prescription of implantable subdermal contraceptive Z30.46 Encounter for surveillance of implantable subdermal contraceptive (includes removal, checking, reinsertion of implant)
Enctr srvlnc implantable subdermal contraceptive; Encounter for checking, reinsertion or removal of implantable subdermal contraceptive ICD-10-CM Diagnosis Code Z30.46 Encounter for surveillance of implantable subdermal contraceptive
11983The insertion and/or removal of the implant are reported using one of the following CPT (Current Procedural Terminology) codes: 11981 Insertion, non-biodegradable drug delivery implant. 11982 Removal, non-biodegradable drug delivery implant. 11983 Removal with reinsertion, non-biodegradable drug delivery implant.
Z30. 46 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z30. 46 became effective on October 1, 2021.
Encounter for surveillance of implantable subdermal contraceptive46 for Encounter for surveillance of implantable subdermal contraceptive is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
11983Possible billing codes for NEXPLANONPossible CPT ® Administration CodesDefinition11981Insertion, non-biodegradable drug delivery implant.11982Removal, non-biodegradable drug delivery implant.11983Removal, with reinsertion, non-biodegradable drug delivery implant.
V45.52V45. 52 - Presence of subdermal contraceptive implant. ICD-10-CM. Centers for Medicare and Medicaid Services and the National Center for Health Statistics; 2018.
Nexplanon is a single-rod subdermal contraceptive implant containing a total of 68 mg of etonogestrel (a progestin being the active metabolite of desogestrel derived from the 19- nortestosterone), which is released daily at low doses (25–70 μg) through a rate-limiting membrane, allowing a contraceptive effect lasting ...Jan 31, 2019
Presence of (intrauterine) contraceptive device Z97. 5 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z97. 5 became effective on October 1, 2021.
Subdermal contraceptive implants involve the delivery of a steroid progestin from polymer capsules or rods placed under the skin. The hormone diffuses out slowly at a stable rate, providing contraceptive effectiveness for 1-5 years. The period of protection depends upon the specific progestin and the type of polymer.
2022 ICD-10-CM Diagnosis Code Z30. 49: Encounter for surveillance of other contraceptives.
It is essential that you code and bill BOTH the CPT code 58301 for the IUD removal and 58300 for the IUD reinsertion with a modifier 51 on the second procedure in order to be paid appropriately for the services.
The insertion and/or removal of IUDs are reported using one of the following CPT codes:58300 Insertion of IUD.58301 Removal of IUD.
Dr. O. reports codes 58301 (removal) and 58300-51 (insertion) and J7298 (levonorgestrel-releasing intrauterine contraceptive system [Mirena®], 52 mg [5 year duration]) for the IUD. The diagnosis code is Z30. 433 (removal and reinsertion of IUD).
If reporting both an E/M service and a procedure, the documentation must indicate a significant, separately identifiable E/M service. The documentation must indicate either the key components (history, physical examination, and medical decision making) or time spent counseling. In order to report an evaluation and management visit based on time, more than 50% of the visit must be spent counseling the patient. When time is the determining factor for the selection of the level of service, documentation should include the following: 1 The total length of time spent by the physician with the patient, 2 The time spent in counseling and/or coordination of care activities, and 3 A description of the content of the counseling and/or coordination of care activities.
CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use.
If discussion of contraceptive options takes place during the same encounter as a procedure, such as insertion of a contraceptive implant or IUD, it may or may not be appropriate to report both an E/M services code and the procedure code:
The CPT procedure codes do not include the cost of the supply. Report the supply separately using a HCPCS (Healthcare Procedural Coding System) code: J7307 Etonogestrel [contraceptive] implant system, including implant and supplies.